Global Nonnarcotic Analgesics Production, Demand and Key Producers, 2022-2028
Nonnarcotic analgesics refer to non steroidal anti-inflammatory drugs that have nothing to do with or have little to do with central opioid receptors
This report studies the global Nonnarcotic Analgesics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nonnarcotic Analgesics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nonnarcotic Analgesics that contribute to its increasing demand across many markets.
The global Nonnarcotic Analgesics market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Nonnarcotic Analgesics total production and demand, 2017-2028, (K Units)
Global Nonnarcotic Analgesics total production value, 2017-2028, (USD Million)
Global Nonnarcotic Analgesics production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Nonnarcotic Analgesics consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Nonnarcotic Analgesics domestic production, consumption, key domestic manufacturers and share
Global Nonnarcotic Analgesics production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Nonnarcotic Analgesics production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Nonnarcotic Analgesics production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Nonnarcotic Analgesics market based on the following parameters – headquarters, production locations, products portfolio, Nonnarcotic Analgesics revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nonnarcotic Analgesics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Nonnarcotic Analgesics Market, By Region:
1. How big is the global Nonnarcotic Analgesics market?
2. What is the demand of the global Nonnarcotic Analgesics market?
3. What is the year over year growth of the global Nonnarcotic Analgesics market?
4. What is the production and production value of the global Nonnarcotic Analgesics market?
5. Who are the key producers in the global Nonnarcotic Analgesics market?
6. What are the growth factors driving the market demand?
This report studies the global Nonnarcotic Analgesics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nonnarcotic Analgesics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nonnarcotic Analgesics that contribute to its increasing demand across many markets.
The global Nonnarcotic Analgesics market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Nonnarcotic Analgesics total production and demand, 2017-2028, (K Units)
Global Nonnarcotic Analgesics total production value, 2017-2028, (USD Million)
Global Nonnarcotic Analgesics production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Nonnarcotic Analgesics consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Nonnarcotic Analgesics domestic production, consumption, key domestic manufacturers and share
Global Nonnarcotic Analgesics production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Nonnarcotic Analgesics production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Nonnarcotic Analgesics production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Nonnarcotic Analgesics market based on the following parameters – headquarters, production locations, products portfolio, Nonnarcotic Analgesics revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nonnarcotic Analgesics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Nonnarcotic Analgesics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Salicylates
- Anilines
- Pyrazolones
- Other Organic Acids
- Hospital
- Pharmacy
- Specialist Clinic
- Other
- GlaxoSmithKline Consumer Healthcare
- Bayer Corporation
- Atnahs Pharma
- Baudax Bio
- Prestige Brands, Inc.
- Cumberland Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company
- Pfizer Inc.
- McNeil Consumer Healthcare
- Eli Lilly and Company
- Sun Pharmaceutical Industries
- Validus Pharmaceuticals
- Novartis Consumer Health
- Pacira Pharmaceuticals, Inc.
- Almatica Pharma
- Actavis
- Arbor Pharmaceuticals, LLC
- PLx Pharma Inc.
- Heron Therapeutics
- Assertio Therapeutics, Inc.
- Zyla Life Sciences
- Jazz Pharmaceuticals plc
1. How big is the global Nonnarcotic Analgesics market?
2. What is the demand of the global Nonnarcotic Analgesics market?
3. What is the year over year growth of the global Nonnarcotic Analgesics market?
4. What is the production and production value of the global Nonnarcotic Analgesics market?
5. Who are the key producers in the global Nonnarcotic Analgesics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nonnarcotic Analgesics Introduction
1.2 World Nonnarcotic Analgesics Supply & Forecast
1.2.1 World Nonnarcotic Analgesics Production Value (2017 & 2021 & 2028)
1.2.2 World Nonnarcotic Analgesics Production (2017-2028)
1.2.3 World Nonnarcotic Analgesics Pricing Trends (2017-2028)
1.3 World Nonnarcotic Analgesics Production by Region
1.3.1 World Nonnarcotic Analgesics Production Value by Region (2017-2028)
1.3.2 World Nonnarcotic Analgesics Production by Region (2017-2028)
1.3.3 World Nonnarcotic Analgesics Average Price by Region (2017-2028)
1.3.4 North America Nonnarcotic Analgesics Production (2017-2028)
1.3.5 Europe Nonnarcotic Analgesics Production (2017-2028)
1.3.6 China Nonnarcotic Analgesics Production (2017-2028)
1.3.7 Japan Nonnarcotic Analgesics Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nonnarcotic Analgesics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nonnarcotic Analgesics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nonnarcotic Analgesics Demand (2017-2028)
2.2 World Nonnarcotic Analgesics Consumption by Region
2.2.1 World Nonnarcotic Analgesics Consumption by Region (2017-2022)
2.2.2 World Nonnarcotic Analgesics Consumption Forecast by Region (2023-2028)
2.3 United States Nonnarcotic Analgesics Consumption (2017-2028)
2.4 China Nonnarcotic Analgesics Consumption (2017-2028)
2.5 Europe Nonnarcotic Analgesics Consumption (2017-2028)
2.6 Japan Nonnarcotic Analgesics Consumption (2017-2028)
2.7 South Korea Nonnarcotic Analgesics Consumption (2017-2028)
2.8 ASEAN Nonnarcotic Analgesics Consumption (2017-2028)
2.9 India Nonnarcotic Analgesics Consumption (2017-2028)
3 WORLD NONNARCOTIC ANALGESICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nonnarcotic Analgesics Production Value by Manufacturer (2017-2022)
3.2 World Nonnarcotic Analgesics Production by Manufacturer (2017-2022)
3.3 World Nonnarcotic Analgesics Average Price by Manufacturer (2017-2022)
3.4 Nonnarcotic Analgesics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nonnarcotic Analgesics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nonnarcotic Analgesics in 2021
3.5.3 Global Concentration Ratios (CR8) for Nonnarcotic Analgesics in 2021
3.6 Nonnarcotic Analgesics Market: Overall Company Footprint Analysis
3.6.1 Nonnarcotic Analgesics Market: Region Footprint
3.6.2 Nonnarcotic Analgesics Market: Company Product Type Footprint
3.6.3 Nonnarcotic Analgesics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nonnarcotic Analgesics Production Value Comparison
4.1.1 United States VS China: Nonnarcotic Analgesics Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Nonnarcotic Analgesics Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Nonnarcotic Analgesics Production Comparison
4.2.1 United States VS China: Nonnarcotic Analgesics Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Nonnarcotic Analgesics Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Nonnarcotic Analgesics Consumption Comparison
4.3.1 United States VS China: Nonnarcotic Analgesics Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Nonnarcotic Analgesics Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Nonnarcotic Analgesics in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
4.5 China Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Nonnarcotic Analgesics in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Nonnarcotic Analgesics in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Nonnarcotic Analgesics Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Salicylates
5.2.2 Anilines
5.2.3 Pyrazolones
5.2.4 Other Organic Acids
5.3 Market Segment by Type
5.3.1 World Nonnarcotic Analgesics Production by Type (2017-2028)
5.3.2 World Nonnarcotic Analgesics Production Value by Type (2017-2028)
5.3.3 World Nonnarcotic Analgesics Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nonnarcotic Analgesics Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Specialist Clinic
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Nonnarcotic Analgesics Production by Application (2017-2028)
6.3.2 World Nonnarcotic Analgesics Production Value by Application (2017-2028)
6.3.3 World Nonnarcotic Analgesics Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GlaxoSmithKline Consumer Healthcare
7.1.1 GlaxoSmithKline Consumer Healthcare Details
7.1.2 GlaxoSmithKline Consumer Healthcare Major Business
7.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product and Services
7.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
7.1.6 GlaxoSmithKline Consumer Healthcare Competitive Strengths & Weaknesses
7.2 Bayer Corporation
7.2.1 Bayer Corporation Details
7.2.2 Bayer Corporation Major Business
7.2.3 Bayer Corporation Nonnarcotic Analgesics Product and Services
7.2.4 Bayer Corporation Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bayer Corporation Recent Developments/Updates
7.2.6 Bayer Corporation Competitive Strengths & Weaknesses
7.3 Atnahs Pharma
7.3.1 Atnahs Pharma Details
7.3.2 Atnahs Pharma Major Business
7.3.3 Atnahs Pharma Nonnarcotic Analgesics Product and Services
7.3.4 Atnahs Pharma Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Atnahs Pharma Recent Developments/Updates
7.3.6 Atnahs Pharma Competitive Strengths & Weaknesses
7.4 Baudax Bio
7.4.1 Baudax Bio Details
7.4.2 Baudax Bio Major Business
7.4.3 Baudax Bio Nonnarcotic Analgesics Product and Services
7.4.4 Baudax Bio Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Baudax Bio Recent Developments/Updates
7.4.6 Baudax Bio Competitive Strengths & Weaknesses
7.5 Prestige Brands, Inc.
7.5.1 Prestige Brands, Inc. Details
7.5.2 Prestige Brands, Inc. Major Business
7.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Product and Services
7.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Prestige Brands, Inc. Recent Developments/Updates
7.5.6 Prestige Brands, Inc. Competitive Strengths & Weaknesses
7.6 Cumberland Pharmaceuticals, Inc.
7.6.1 Cumberland Pharmaceuticals, Inc. Details
7.6.2 Cumberland Pharmaceuticals, Inc. Major Business
7.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
7.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
7.6.6 Cumberland Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.7 Takeda Pharmaceutical Company
7.7.1 Takeda Pharmaceutical Company Details
7.7.2 Takeda Pharmaceutical Company Major Business
7.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Product and Services
7.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Takeda Pharmaceutical Company Recent Developments/Updates
7.7.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Details
7.8.2 Pfizer Inc. Major Business
7.8.3 Pfizer Inc. Nonnarcotic Analgesics Product and Services
7.8.4 Pfizer Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Pfizer Inc. Recent Developments/Updates
7.8.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.9 McNeil Consumer Healthcare
7.9.1 McNeil Consumer Healthcare Details
7.9.2 McNeil Consumer Healthcare Major Business
7.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Product and Services
7.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 McNeil Consumer Healthcare Recent Developments/Updates
7.9.6 McNeil Consumer Healthcare Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Nonnarcotic Analgesics Product and Services
7.10.4 Eli Lilly and Company Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Details
7.11.2 Sun Pharmaceutical Industries Major Business
7.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Product and Services
7.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.11.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
7.12 Validus Pharmaceuticals
7.12.1 Validus Pharmaceuticals Details
7.12.2 Validus Pharmaceuticals Major Business
7.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Product and Services
7.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Validus Pharmaceuticals Recent Developments/Updates
7.12.6 Validus Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Novartis Consumer Health
7.13.1 Novartis Consumer Health Details
7.13.2 Novartis Consumer Health Major Business
7.13.3 Novartis Consumer Health Nonnarcotic Analgesics Product and Services
7.13.4 Novartis Consumer Health Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Novartis Consumer Health Recent Developments/Updates
7.13.6 Novartis Consumer Health Competitive Strengths & Weaknesses
7.14 Pacira Pharmaceuticals, Inc.
7.14.1 Pacira Pharmaceuticals, Inc. Details
7.14.2 Pacira Pharmaceuticals, Inc. Major Business
7.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
7.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Pacira Pharmaceuticals, Inc. Recent Developments/Updates
7.14.6 Pacira Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.15 Almatica Pharma
7.15.1 Almatica Pharma Details
7.15.2 Almatica Pharma Major Business
7.15.3 Almatica Pharma Nonnarcotic Analgesics Product and Services
7.15.4 Almatica Pharma Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Almatica Pharma Recent Developments/Updates
7.15.6 Almatica Pharma Competitive Strengths & Weaknesses
7.16 Actavis
7.16.1 Actavis Details
7.16.2 Actavis Major Business
7.16.3 Actavis Nonnarcotic Analgesics Product and Services
7.16.4 Actavis Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Actavis Recent Developments/Updates
7.16.6 Actavis Competitive Strengths & Weaknesses
7.17 Arbor Pharmaceuticals, LLC
7.17.1 Arbor Pharmaceuticals, LLC Details
7.17.2 Arbor Pharmaceuticals, LLC Major Business
7.17.3 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product and Services
7.17.4 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Arbor Pharmaceuticals, LLC Recent Developments/Updates
7.17.6 Arbor Pharmaceuticals, LLC Competitive Strengths & Weaknesses
7.18 PLx Pharma Inc.
7.18.1 PLx Pharma Inc. Details
7.18.2 PLx Pharma Inc. Major Business
7.18.3 PLx Pharma Inc. Nonnarcotic Analgesics Product and Services
7.18.4 PLx Pharma Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 PLx Pharma Inc. Recent Developments/Updates
7.18.6 PLx Pharma Inc. Competitive Strengths & Weaknesses
7.19 Heron Therapeutics
7.19.1 Heron Therapeutics Details
7.19.2 Heron Therapeutics Major Business
7.19.3 Heron Therapeutics Nonnarcotic Analgesics Product and Services
7.19.4 Heron Therapeutics Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Heron Therapeutics Recent Developments/Updates
7.19.6 Heron Therapeutics Competitive Strengths & Weaknesses
7.20 Assertio Therapeutics, Inc.
7.20.1 Assertio Therapeutics, Inc. Details
7.20.2 Assertio Therapeutics, Inc. Major Business
7.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product and Services
7.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Assertio Therapeutics, Inc. Recent Developments/Updates
7.20.6 Assertio Therapeutics, Inc. Competitive Strengths & Weaknesses
7.21 Zyla Life Sciences
7.21.1 Zyla Life Sciences Details
7.21.2 Zyla Life Sciences Major Business
7.21.3 Zyla Life Sciences Nonnarcotic Analgesics Product and Services
7.21.4 Zyla Life Sciences Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Zyla Life Sciences Recent Developments/Updates
7.21.6 Zyla Life Sciences Competitive Strengths & Weaknesses
7.22 Jazz Pharmaceuticals plc
7.22.1 Jazz Pharmaceuticals plc Details
7.22.2 Jazz Pharmaceuticals plc Major Business
7.22.3 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product and Services
7.22.4 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 Jazz Pharmaceuticals plc Recent Developments/Updates
7.22.6 Jazz Pharmaceuticals plc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Nonnarcotic Analgesics and Key Manufacturers
8.2 Nonnarcotic Analgesics Manufacturing Costs
8.3 Nonnarcotic Analgesics Production Process
8.4 Nonnarcotic Analgesics Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Nonnarcotic Analgesics Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Nonnarcotic Analgesics Typical Distributors
9.3 Nonnarcotic Analgesics Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Nonnarcotic Analgesics Introduction
1.2 World Nonnarcotic Analgesics Supply & Forecast
1.2.1 World Nonnarcotic Analgesics Production Value (2017 & 2021 & 2028)
1.2.2 World Nonnarcotic Analgesics Production (2017-2028)
1.2.3 World Nonnarcotic Analgesics Pricing Trends (2017-2028)
1.3 World Nonnarcotic Analgesics Production by Region
1.3.1 World Nonnarcotic Analgesics Production Value by Region (2017-2028)
1.3.2 World Nonnarcotic Analgesics Production by Region (2017-2028)
1.3.3 World Nonnarcotic Analgesics Average Price by Region (2017-2028)
1.3.4 North America Nonnarcotic Analgesics Production (2017-2028)
1.3.5 Europe Nonnarcotic Analgesics Production (2017-2028)
1.3.6 China Nonnarcotic Analgesics Production (2017-2028)
1.3.7 Japan Nonnarcotic Analgesics Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nonnarcotic Analgesics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nonnarcotic Analgesics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nonnarcotic Analgesics Demand (2017-2028)
2.2 World Nonnarcotic Analgesics Consumption by Region
2.2.1 World Nonnarcotic Analgesics Consumption by Region (2017-2022)
2.2.2 World Nonnarcotic Analgesics Consumption Forecast by Region (2023-2028)
2.3 United States Nonnarcotic Analgesics Consumption (2017-2028)
2.4 China Nonnarcotic Analgesics Consumption (2017-2028)
2.5 Europe Nonnarcotic Analgesics Consumption (2017-2028)
2.6 Japan Nonnarcotic Analgesics Consumption (2017-2028)
2.7 South Korea Nonnarcotic Analgesics Consumption (2017-2028)
2.8 ASEAN Nonnarcotic Analgesics Consumption (2017-2028)
2.9 India Nonnarcotic Analgesics Consumption (2017-2028)
3 WORLD NONNARCOTIC ANALGESICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nonnarcotic Analgesics Production Value by Manufacturer (2017-2022)
3.2 World Nonnarcotic Analgesics Production by Manufacturer (2017-2022)
3.3 World Nonnarcotic Analgesics Average Price by Manufacturer (2017-2022)
3.4 Nonnarcotic Analgesics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nonnarcotic Analgesics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nonnarcotic Analgesics in 2021
3.5.3 Global Concentration Ratios (CR8) for Nonnarcotic Analgesics in 2021
3.6 Nonnarcotic Analgesics Market: Overall Company Footprint Analysis
3.6.1 Nonnarcotic Analgesics Market: Region Footprint
3.6.2 Nonnarcotic Analgesics Market: Company Product Type Footprint
3.6.3 Nonnarcotic Analgesics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nonnarcotic Analgesics Production Value Comparison
4.1.1 United States VS China: Nonnarcotic Analgesics Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Nonnarcotic Analgesics Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Nonnarcotic Analgesics Production Comparison
4.2.1 United States VS China: Nonnarcotic Analgesics Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Nonnarcotic Analgesics Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Nonnarcotic Analgesics Consumption Comparison
4.3.1 United States VS China: Nonnarcotic Analgesics Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Nonnarcotic Analgesics Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Nonnarcotic Analgesics in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
4.5 China Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Nonnarcotic Analgesics in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Nonnarcotic Analgesics Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Nonnarcotic Analgesics in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Nonnarcotic Analgesics Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Salicylates
5.2.2 Anilines
5.2.3 Pyrazolones
5.2.4 Other Organic Acids
5.3 Market Segment by Type
5.3.1 World Nonnarcotic Analgesics Production by Type (2017-2028)
5.3.2 World Nonnarcotic Analgesics Production Value by Type (2017-2028)
5.3.3 World Nonnarcotic Analgesics Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nonnarcotic Analgesics Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Specialist Clinic
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Nonnarcotic Analgesics Production by Application (2017-2028)
6.3.2 World Nonnarcotic Analgesics Production Value by Application (2017-2028)
6.3.3 World Nonnarcotic Analgesics Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GlaxoSmithKline Consumer Healthcare
7.1.1 GlaxoSmithKline Consumer Healthcare Details
7.1.2 GlaxoSmithKline Consumer Healthcare Major Business
7.1.3 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product and Services
7.1.4 GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
7.1.6 GlaxoSmithKline Consumer Healthcare Competitive Strengths & Weaknesses
7.2 Bayer Corporation
7.2.1 Bayer Corporation Details
7.2.2 Bayer Corporation Major Business
7.2.3 Bayer Corporation Nonnarcotic Analgesics Product and Services
7.2.4 Bayer Corporation Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bayer Corporation Recent Developments/Updates
7.2.6 Bayer Corporation Competitive Strengths & Weaknesses
7.3 Atnahs Pharma
7.3.1 Atnahs Pharma Details
7.3.2 Atnahs Pharma Major Business
7.3.3 Atnahs Pharma Nonnarcotic Analgesics Product and Services
7.3.4 Atnahs Pharma Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Atnahs Pharma Recent Developments/Updates
7.3.6 Atnahs Pharma Competitive Strengths & Weaknesses
7.4 Baudax Bio
7.4.1 Baudax Bio Details
7.4.2 Baudax Bio Major Business
7.4.3 Baudax Bio Nonnarcotic Analgesics Product and Services
7.4.4 Baudax Bio Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Baudax Bio Recent Developments/Updates
7.4.6 Baudax Bio Competitive Strengths & Weaknesses
7.5 Prestige Brands, Inc.
7.5.1 Prestige Brands, Inc. Details
7.5.2 Prestige Brands, Inc. Major Business
7.5.3 Prestige Brands, Inc. Nonnarcotic Analgesics Product and Services
7.5.4 Prestige Brands, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Prestige Brands, Inc. Recent Developments/Updates
7.5.6 Prestige Brands, Inc. Competitive Strengths & Weaknesses
7.6 Cumberland Pharmaceuticals, Inc.
7.6.1 Cumberland Pharmaceuticals, Inc. Details
7.6.2 Cumberland Pharmaceuticals, Inc. Major Business
7.6.3 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
7.6.4 Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
7.6.6 Cumberland Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.7 Takeda Pharmaceutical Company
7.7.1 Takeda Pharmaceutical Company Details
7.7.2 Takeda Pharmaceutical Company Major Business
7.7.3 Takeda Pharmaceutical Company Nonnarcotic Analgesics Product and Services
7.7.4 Takeda Pharmaceutical Company Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Takeda Pharmaceutical Company Recent Developments/Updates
7.7.6 Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Details
7.8.2 Pfizer Inc. Major Business
7.8.3 Pfizer Inc. Nonnarcotic Analgesics Product and Services
7.8.4 Pfizer Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Pfizer Inc. Recent Developments/Updates
7.8.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.9 McNeil Consumer Healthcare
7.9.1 McNeil Consumer Healthcare Details
7.9.2 McNeil Consumer Healthcare Major Business
7.9.3 McNeil Consumer Healthcare Nonnarcotic Analgesics Product and Services
7.9.4 McNeil Consumer Healthcare Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 McNeil Consumer Healthcare Recent Developments/Updates
7.9.6 McNeil Consumer Healthcare Competitive Strengths & Weaknesses
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Details
7.10.2 Eli Lilly and Company Major Business
7.10.3 Eli Lilly and Company Nonnarcotic Analgesics Product and Services
7.10.4 Eli Lilly and Company Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Eli Lilly and Company Recent Developments/Updates
7.10.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Details
7.11.2 Sun Pharmaceutical Industries Major Business
7.11.3 Sun Pharmaceutical Industries Nonnarcotic Analgesics Product and Services
7.11.4 Sun Pharmaceutical Industries Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.11.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
7.12 Validus Pharmaceuticals
7.12.1 Validus Pharmaceuticals Details
7.12.2 Validus Pharmaceuticals Major Business
7.12.3 Validus Pharmaceuticals Nonnarcotic Analgesics Product and Services
7.12.4 Validus Pharmaceuticals Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Validus Pharmaceuticals Recent Developments/Updates
7.12.6 Validus Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Novartis Consumer Health
7.13.1 Novartis Consumer Health Details
7.13.2 Novartis Consumer Health Major Business
7.13.3 Novartis Consumer Health Nonnarcotic Analgesics Product and Services
7.13.4 Novartis Consumer Health Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Novartis Consumer Health Recent Developments/Updates
7.13.6 Novartis Consumer Health Competitive Strengths & Weaknesses
7.14 Pacira Pharmaceuticals, Inc.
7.14.1 Pacira Pharmaceuticals, Inc. Details
7.14.2 Pacira Pharmaceuticals, Inc. Major Business
7.14.3 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
7.14.4 Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Pacira Pharmaceuticals, Inc. Recent Developments/Updates
7.14.6 Pacira Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.15 Almatica Pharma
7.15.1 Almatica Pharma Details
7.15.2 Almatica Pharma Major Business
7.15.3 Almatica Pharma Nonnarcotic Analgesics Product and Services
7.15.4 Almatica Pharma Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Almatica Pharma Recent Developments/Updates
7.15.6 Almatica Pharma Competitive Strengths & Weaknesses
7.16 Actavis
7.16.1 Actavis Details
7.16.2 Actavis Major Business
7.16.3 Actavis Nonnarcotic Analgesics Product and Services
7.16.4 Actavis Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Actavis Recent Developments/Updates
7.16.6 Actavis Competitive Strengths & Weaknesses
7.17 Arbor Pharmaceuticals, LLC
7.17.1 Arbor Pharmaceuticals, LLC Details
7.17.2 Arbor Pharmaceuticals, LLC Major Business
7.17.3 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product and Services
7.17.4 Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Arbor Pharmaceuticals, LLC Recent Developments/Updates
7.17.6 Arbor Pharmaceuticals, LLC Competitive Strengths & Weaknesses
7.18 PLx Pharma Inc.
7.18.1 PLx Pharma Inc. Details
7.18.2 PLx Pharma Inc. Major Business
7.18.3 PLx Pharma Inc. Nonnarcotic Analgesics Product and Services
7.18.4 PLx Pharma Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 PLx Pharma Inc. Recent Developments/Updates
7.18.6 PLx Pharma Inc. Competitive Strengths & Weaknesses
7.19 Heron Therapeutics
7.19.1 Heron Therapeutics Details
7.19.2 Heron Therapeutics Major Business
7.19.3 Heron Therapeutics Nonnarcotic Analgesics Product and Services
7.19.4 Heron Therapeutics Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Heron Therapeutics Recent Developments/Updates
7.19.6 Heron Therapeutics Competitive Strengths & Weaknesses
7.20 Assertio Therapeutics, Inc.
7.20.1 Assertio Therapeutics, Inc. Details
7.20.2 Assertio Therapeutics, Inc. Major Business
7.20.3 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product and Services
7.20.4 Assertio Therapeutics, Inc. Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Assertio Therapeutics, Inc. Recent Developments/Updates
7.20.6 Assertio Therapeutics, Inc. Competitive Strengths & Weaknesses
7.21 Zyla Life Sciences
7.21.1 Zyla Life Sciences Details
7.21.2 Zyla Life Sciences Major Business
7.21.3 Zyla Life Sciences Nonnarcotic Analgesics Product and Services
7.21.4 Zyla Life Sciences Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Zyla Life Sciences Recent Developments/Updates
7.21.6 Zyla Life Sciences Competitive Strengths & Weaknesses
7.22 Jazz Pharmaceuticals plc
7.22.1 Jazz Pharmaceuticals plc Details
7.22.2 Jazz Pharmaceuticals plc Major Business
7.22.3 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product and Services
7.22.4 Jazz Pharmaceuticals plc Nonnarcotic Analgesics Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 Jazz Pharmaceuticals plc Recent Developments/Updates
7.22.6 Jazz Pharmaceuticals plc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Nonnarcotic Analgesics and Key Manufacturers
8.2 Nonnarcotic Analgesics Manufacturing Costs
8.3 Nonnarcotic Analgesics Production Process
8.4 Nonnarcotic Analgesics Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Nonnarcotic Analgesics Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Nonnarcotic Analgesics Typical Distributors
9.3 Nonnarcotic Analgesics Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Nonnarcotic Analgesics Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Nonnarcotic Analgesics Production Value by Region (2017-2022) & (USD Million)
Table 3. World Nonnarcotic Analgesics Production Value by Region (2023-2028) & (USD Million)
Table 4. World Nonnarcotic Analgesics Production Value Market Share by Region (2017-2022)
Table 5. World Nonnarcotic Analgesics Production Value Market Share by Region (2023-2028)
Table 6. World Nonnarcotic Analgesics Production by Region (2017-2022) & (K Units)
Table 7. World Nonnarcotic Analgesics Production by Region (2023-2028) & (K Units)
Table 8. World Nonnarcotic Analgesics Production Market Share by Region (2017-2022)
Table 9. World Nonnarcotic Analgesics Production Market Share by Region (2023-2028)
Table 10. World Nonnarcotic Analgesics Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Nonnarcotic Analgesics Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Nonnarcotic Analgesics Major Market Trends
Table 13. World Nonnarcotic Analgesics Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Nonnarcotic Analgesics Consumption by Region (2017-2022) & (K Units)
Table 15. World Nonnarcotic Analgesics Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Nonnarcotic Analgesics Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Nonnarcotic Analgesics Producers in 2021
Table 18. World Nonnarcotic Analgesics Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Nonnarcotic Analgesics Producers in 2021
Table 20. World Nonnarcotic Analgesics Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Nonnarcotic Analgesics Company Evaluation Quadrant
Table 22. World Nonnarcotic Analgesics Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Nonnarcotic Analgesics Production Site of Key Manufacturer
Table 24. Nonnarcotic Analgesics Market: Company Product Type Footprint
Table 25. Nonnarcotic Analgesics Market: Company Product Application Footprint
Table 26. Nonnarcotic Analgesics Competitive Factors
Table 27. Nonnarcotic Analgesics New Entrant and Capacity Expansion Plans
Table 28. Nonnarcotic Analgesics Mergers & Acquisitions Activity
Table 29. United States VS China Nonnarcotic Analgesics Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Nonnarcotic Analgesics Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Nonnarcotic Analgesics Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Nonnarcotic Analgesics in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Nonnarcotic Analgesics in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Nonnarcotic Analgesics in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Nonnarcotic Analgesics Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Nonnarcotic Analgesics Production by Type (2017-2022) & (K Units)
Table 49. World Nonnarcotic Analgesics Production by Type (2023-2028) & (K Units)
Table 50. World Nonnarcotic Analgesics Production Value by Type (2017-2022) & (USD Million)
Table 51. World Nonnarcotic Analgesics Production Value by Type (2023-2028) & (USD Million)
Table 52. World Nonnarcotic Analgesics Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Nonnarcotic Analgesics Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Nonnarcotic Analgesics Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Nonnarcotic Analgesics Production by Application (2017-2022) & (K Units)
Table 56. World Nonnarcotic Analgesics Production by Application (2023-2028) & (K Units)
Table 57. World Nonnarcotic Analgesics Production Value by Application (2017-2022) & (USD Million)
Table 58. World Nonnarcotic Analgesics Production Value by Application (2023-2028) & (USD Million)
Table 59. World Nonnarcotic Analgesics Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Nonnarcotic Analgesics Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GlaxoSmithKline Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Consumer Healthcare Major Business
Table 63. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product and Services
Table 64. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
Table 66. GlaxoSmithKline Consumer Healthcare Competitive Strengths & Weaknesses
Table 67. Bayer Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Corporation Major Business
Table 69. Bayer Corporation Nonnarcotic Analgesics Product and Services
Table 70. Bayer Corporation Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bayer Corporation Recent Developments/Updates
Table 72. Bayer Corporation Competitive Strengths & Weaknesses
Table 73. Atnahs Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Atnahs Pharma Major Business
Table 75. Atnahs Pharma Nonnarcotic Analgesics Product and Services
Table 76. Atnahs Pharma Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Atnahs Pharma Recent Developments/Updates
Table 78. Atnahs Pharma Competitive Strengths & Weaknesses
Table 79. Baudax Bio Basic Information, Manufacturing Base and Competitors
Table 80. Baudax Bio Major Business
Table 81. Baudax Bio Nonnarcotic Analgesics Product and Services
Table 82. Baudax Bio Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Baudax Bio Recent Developments/Updates
Table 84. Baudax Bio Competitive Strengths & Weaknesses
Table 85. Prestige Brands, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Prestige Brands, Inc. Major Business
Table 87. Prestige Brands, Inc. Nonnarcotic Analgesics Product and Services
Table 88. Prestige Brands, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Prestige Brands, Inc. Recent Developments/Updates
Table 90. Prestige Brands, Inc. Competitive Strengths & Weaknesses
Table 91. Cumberland Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Cumberland Pharmaceuticals, Inc. Major Business
Table 93. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
Table 94. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
Table 96. Cumberland Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 97. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Pharmaceutical Company Major Business
Table 99. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product and Services
Table 100. Takeda Pharmaceutical Company Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Takeda Pharmaceutical Company Recent Developments/Updates
Table 102. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
Table 103. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Inc. Major Business
Table 105. Pfizer Inc. Nonnarcotic Analgesics Product and Services
Table 106. Pfizer Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Pfizer Inc. Recent Developments/Updates
Table 108. Pfizer Inc. Competitive Strengths & Weaknesses
Table 109. McNeil Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table 110. McNeil Consumer Healthcare Major Business
Table 111. McNeil Consumer Healthcare Nonnarcotic Analgesics Product and Services
Table 112. McNeil Consumer Healthcare Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. McNeil Consumer Healthcare Recent Developments/Updates
Table 114. McNeil Consumer Healthcare Competitive Strengths & Weaknesses
Table 115. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly and Company Major Business
Table 117. Eli Lilly and Company Nonnarcotic Analgesics Product and Services
Table 118. Eli Lilly and Company Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 121. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 122. Sun Pharmaceutical Industries Major Business
Table 123. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product and Services
Table 124. Sun Pharmaceutical Industries Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sun Pharmaceutical Industries Recent Developments/Updates
Table 126. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 127. Validus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Validus Pharmaceuticals Major Business
Table 129. Validus Pharmaceuticals Nonnarcotic Analgesics Product and Services
Table 130. Validus Pharmaceuticals Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Validus Pharmaceuticals Recent Developments/Updates
Table 132. Validus Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Novartis Consumer Health Basic Information, Manufacturing Base and Competitors
Table 134. Novartis Consumer Health Major Business
Table 135. Novartis Consumer Health Nonnarcotic Analgesics Product and Services
Table 136. Novartis Consumer Health Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Novartis Consumer Health Recent Developments/Updates
Table 138. Novartis Consumer Health Competitive Strengths & Weaknesses
Table 139. Pacira Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Pacira Pharmaceuticals, Inc. Major Business
Table 141. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
Table 142. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Pacira Pharmaceuticals, Inc. Recent Developments/Updates
Table 144. Pacira Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 145. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 146. Almatica Pharma Major Business
Table 147. Almatica Pharma Nonnarcotic Analgesics Product and Services
Table 148. Almatica Pharma Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Almatica Pharma Recent Developments/Updates
Table 150. Almatica Pharma Competitive Strengths & Weaknesses
Table 151. Actavis Basic Information, Manufacturing Base and Competitors
Table 152. Actavis Major Business
Table 153. Actavis Nonnarcotic Analgesics Product and Services
Table 154. Actavis Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Actavis Recent Developments/Updates
Table 156. Actavis Competitive Strengths & Weaknesses
Table 157. Arbor Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 158. Arbor Pharmaceuticals, LLC Major Business
Table 159. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product and Services
Table 160. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Arbor Pharmaceuticals, LLC Recent Developments/Updates
Table 162. Arbor Pharmaceuticals, LLC Competitive Strengths & Weaknesses
Table 163. PLx Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 164. PLx Pharma Inc. Major Business
Table 165. PLx Pharma Inc. Nonnarcotic Analgesics Product and Services
Table 166. PLx Pharma Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. PLx Pharma Inc. Recent Developments/Updates
Table 168. PLx Pharma Inc. Competitive Strengths & Weaknesses
Table 169. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 170. Heron Therapeutics Major Business
Table 171. Heron Therapeutics Nonnarcotic Analgesics Product and Services
Table 172. Heron Therapeutics Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Heron Therapeutics Recent Developments/Updates
Table 174. Heron Therapeutics Competitive Strengths & Weaknesses
Table 175. Assertio Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 176. Assertio Therapeutics, Inc. Major Business
Table 177. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product and Services
Table 178. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Assertio Therapeutics, Inc. Recent Developments/Updates
Table 180. Assertio Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 181. Zyla Life Sciences Basic Information, Manufacturing Base and Competitors
Table 182. Zyla Life Sciences Major Business
Table 183. Zyla Life Sciences Nonnarcotic Analgesics Product and Services
Table 184. Zyla Life Sciences Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Zyla Life Sciences Recent Developments/Updates
Table 186. Jazz Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 187. Jazz Pharmaceuticals plc Major Business
Table 188. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product and Services
Table 189. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 190. Nonnarcotic Analgesics Raw Material
Table 191. Key Manufacturers of Nonnarcotic Analgesics Raw Materials
Table 192. Nonnarcotic Analgesics Typical Distributors
Table 193. Nonnarcotic Analgesics Typical Customers
Table 1. World Nonnarcotic Analgesics Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Nonnarcotic Analgesics Production Value by Region (2017-2022) & (USD Million)
Table 3. World Nonnarcotic Analgesics Production Value by Region (2023-2028) & (USD Million)
Table 4. World Nonnarcotic Analgesics Production Value Market Share by Region (2017-2022)
Table 5. World Nonnarcotic Analgesics Production Value Market Share by Region (2023-2028)
Table 6. World Nonnarcotic Analgesics Production by Region (2017-2022) & (K Units)
Table 7. World Nonnarcotic Analgesics Production by Region (2023-2028) & (K Units)
Table 8. World Nonnarcotic Analgesics Production Market Share by Region (2017-2022)
Table 9. World Nonnarcotic Analgesics Production Market Share by Region (2023-2028)
Table 10. World Nonnarcotic Analgesics Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Nonnarcotic Analgesics Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Nonnarcotic Analgesics Major Market Trends
Table 13. World Nonnarcotic Analgesics Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Nonnarcotic Analgesics Consumption by Region (2017-2022) & (K Units)
Table 15. World Nonnarcotic Analgesics Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Nonnarcotic Analgesics Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Nonnarcotic Analgesics Producers in 2021
Table 18. World Nonnarcotic Analgesics Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Nonnarcotic Analgesics Producers in 2021
Table 20. World Nonnarcotic Analgesics Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Nonnarcotic Analgesics Company Evaluation Quadrant
Table 22. World Nonnarcotic Analgesics Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Nonnarcotic Analgesics Production Site of Key Manufacturer
Table 24. Nonnarcotic Analgesics Market: Company Product Type Footprint
Table 25. Nonnarcotic Analgesics Market: Company Product Application Footprint
Table 26. Nonnarcotic Analgesics Competitive Factors
Table 27. Nonnarcotic Analgesics New Entrant and Capacity Expansion Plans
Table 28. Nonnarcotic Analgesics Mergers & Acquisitions Activity
Table 29. United States VS China Nonnarcotic Analgesics Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Nonnarcotic Analgesics Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Nonnarcotic Analgesics Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Nonnarcotic Analgesics in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Nonnarcotic Analgesics in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Nonnarcotic Analgesics in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Nonnarcotic Analgesics Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Nonnarcotic Analgesics Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Nonnarcotic Analgesics Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Nonnarcotic Analgesics Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Nonnarcotic Analgesics Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Nonnarcotic Analgesics Production by Type (2017-2022) & (K Units)
Table 49. World Nonnarcotic Analgesics Production by Type (2023-2028) & (K Units)
Table 50. World Nonnarcotic Analgesics Production Value by Type (2017-2022) & (USD Million)
Table 51. World Nonnarcotic Analgesics Production Value by Type (2023-2028) & (USD Million)
Table 52. World Nonnarcotic Analgesics Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Nonnarcotic Analgesics Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Nonnarcotic Analgesics Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Nonnarcotic Analgesics Production by Application (2017-2022) & (K Units)
Table 56. World Nonnarcotic Analgesics Production by Application (2023-2028) & (K Units)
Table 57. World Nonnarcotic Analgesics Production Value by Application (2017-2022) & (USD Million)
Table 58. World Nonnarcotic Analgesics Production Value by Application (2023-2028) & (USD Million)
Table 59. World Nonnarcotic Analgesics Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Nonnarcotic Analgesics Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GlaxoSmithKline Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Consumer Healthcare Major Business
Table 63. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product and Services
Table 64. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
Table 66. GlaxoSmithKline Consumer Healthcare Competitive Strengths & Weaknesses
Table 67. Bayer Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Corporation Major Business
Table 69. Bayer Corporation Nonnarcotic Analgesics Product and Services
Table 70. Bayer Corporation Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bayer Corporation Recent Developments/Updates
Table 72. Bayer Corporation Competitive Strengths & Weaknesses
Table 73. Atnahs Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Atnahs Pharma Major Business
Table 75. Atnahs Pharma Nonnarcotic Analgesics Product and Services
Table 76. Atnahs Pharma Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Atnahs Pharma Recent Developments/Updates
Table 78. Atnahs Pharma Competitive Strengths & Weaknesses
Table 79. Baudax Bio Basic Information, Manufacturing Base and Competitors
Table 80. Baudax Bio Major Business
Table 81. Baudax Bio Nonnarcotic Analgesics Product and Services
Table 82. Baudax Bio Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Baudax Bio Recent Developments/Updates
Table 84. Baudax Bio Competitive Strengths & Weaknesses
Table 85. Prestige Brands, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Prestige Brands, Inc. Major Business
Table 87. Prestige Brands, Inc. Nonnarcotic Analgesics Product and Services
Table 88. Prestige Brands, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Prestige Brands, Inc. Recent Developments/Updates
Table 90. Prestige Brands, Inc. Competitive Strengths & Weaknesses
Table 91. Cumberland Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Cumberland Pharmaceuticals, Inc. Major Business
Table 93. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
Table 94. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
Table 96. Cumberland Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 97. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Pharmaceutical Company Major Business
Table 99. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product and Services
Table 100. Takeda Pharmaceutical Company Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Takeda Pharmaceutical Company Recent Developments/Updates
Table 102. Takeda Pharmaceutical Company Competitive Strengths & Weaknesses
Table 103. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Inc. Major Business
Table 105. Pfizer Inc. Nonnarcotic Analgesics Product and Services
Table 106. Pfizer Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Pfizer Inc. Recent Developments/Updates
Table 108. Pfizer Inc. Competitive Strengths & Weaknesses
Table 109. McNeil Consumer Healthcare Basic Information, Manufacturing Base and Competitors
Table 110. McNeil Consumer Healthcare Major Business
Table 111. McNeil Consumer Healthcare Nonnarcotic Analgesics Product and Services
Table 112. McNeil Consumer Healthcare Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. McNeil Consumer Healthcare Recent Developments/Updates
Table 114. McNeil Consumer Healthcare Competitive Strengths & Weaknesses
Table 115. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 116. Eli Lilly and Company Major Business
Table 117. Eli Lilly and Company Nonnarcotic Analgesics Product and Services
Table 118. Eli Lilly and Company Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 121. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 122. Sun Pharmaceutical Industries Major Business
Table 123. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product and Services
Table 124. Sun Pharmaceutical Industries Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sun Pharmaceutical Industries Recent Developments/Updates
Table 126. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 127. Validus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Validus Pharmaceuticals Major Business
Table 129. Validus Pharmaceuticals Nonnarcotic Analgesics Product and Services
Table 130. Validus Pharmaceuticals Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Validus Pharmaceuticals Recent Developments/Updates
Table 132. Validus Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Novartis Consumer Health Basic Information, Manufacturing Base and Competitors
Table 134. Novartis Consumer Health Major Business
Table 135. Novartis Consumer Health Nonnarcotic Analgesics Product and Services
Table 136. Novartis Consumer Health Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Novartis Consumer Health Recent Developments/Updates
Table 138. Novartis Consumer Health Competitive Strengths & Weaknesses
Table 139. Pacira Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Pacira Pharmaceuticals, Inc. Major Business
Table 141. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product and Services
Table 142. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Pacira Pharmaceuticals, Inc. Recent Developments/Updates
Table 144. Pacira Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 145. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 146. Almatica Pharma Major Business
Table 147. Almatica Pharma Nonnarcotic Analgesics Product and Services
Table 148. Almatica Pharma Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Almatica Pharma Recent Developments/Updates
Table 150. Almatica Pharma Competitive Strengths & Weaknesses
Table 151. Actavis Basic Information, Manufacturing Base and Competitors
Table 152. Actavis Major Business
Table 153. Actavis Nonnarcotic Analgesics Product and Services
Table 154. Actavis Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Actavis Recent Developments/Updates
Table 156. Actavis Competitive Strengths & Weaknesses
Table 157. Arbor Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 158. Arbor Pharmaceuticals, LLC Major Business
Table 159. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Product and Services
Table 160. Arbor Pharmaceuticals, LLC Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Arbor Pharmaceuticals, LLC Recent Developments/Updates
Table 162. Arbor Pharmaceuticals, LLC Competitive Strengths & Weaknesses
Table 163. PLx Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 164. PLx Pharma Inc. Major Business
Table 165. PLx Pharma Inc. Nonnarcotic Analgesics Product and Services
Table 166. PLx Pharma Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. PLx Pharma Inc. Recent Developments/Updates
Table 168. PLx Pharma Inc. Competitive Strengths & Weaknesses
Table 169. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 170. Heron Therapeutics Major Business
Table 171. Heron Therapeutics Nonnarcotic Analgesics Product and Services
Table 172. Heron Therapeutics Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Heron Therapeutics Recent Developments/Updates
Table 174. Heron Therapeutics Competitive Strengths & Weaknesses
Table 175. Assertio Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 176. Assertio Therapeutics, Inc. Major Business
Table 177. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product and Services
Table 178. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Assertio Therapeutics, Inc. Recent Developments/Updates
Table 180. Assertio Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 181. Zyla Life Sciences Basic Information, Manufacturing Base and Competitors
Table 182. Zyla Life Sciences Major Business
Table 183. Zyla Life Sciences Nonnarcotic Analgesics Product and Services
Table 184. Zyla Life Sciences Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Zyla Life Sciences Recent Developments/Updates
Table 186. Jazz Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 187. Jazz Pharmaceuticals plc Major Business
Table 188. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Product and Services
Table 189. Jazz Pharmaceuticals plc Nonnarcotic Analgesics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 190. Nonnarcotic Analgesics Raw Material
Table 191. Key Manufacturers of Nonnarcotic Analgesics Raw Materials
Table 192. Nonnarcotic Analgesics Typical Distributors
Table 193. Nonnarcotic Analgesics Typical Customers
LIST OF FIGURES
Figure 1. Nonnarcotic Analgesics Picture
Figure 2. World Nonnarcotic Analgesics Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Nonnarcotic Analgesics Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 5. World Nonnarcotic Analgesics Average Price (2017-2028) & (US$/Unit)
Figure 6. World Nonnarcotic Analgesics Production Value Market Share by Region (2017-2028)
Figure 7. World Nonnarcotic Analgesics Production Market Share by Region (2017-2028)
Figure 8. North America Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 9. Europe Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 10. China Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 11. Japan Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 12. Nonnarcotic Analgesics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nonnarcotic Analgesics Demand (2017-2028) & (K Units)
Figure 15. World Nonnarcotic Analgesics Consumption Market Share by Region (2017-2028)
Figure 16. United States Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 17. China Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 18. Europe Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 19. Japan Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 20. South Korea Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 22. India Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Nonnarcotic Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nonnarcotic Analgesics Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nonnarcotic Analgesics Markets in 2021
Figure 26. United States VS China: Nonnarcotic Analgesics Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Nonnarcotic Analgesics Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Nonnarcotic Analgesics Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Nonnarcotic Analgesics in United States
Figure 30. Key Producers and Market Share of Nonnarcotic Analgesics in China
Figure 31. Key Producers and Market Share of Nonnarcotic Analgesics in Rest of World
Figure 32. World Nonnarcotic Analgesics Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Nonnarcotic Analgesics Production Value Market Share by Type in 2021
Figure 34. Salicylates
Figure 35. Anilines
Figure 36. Pyrazolones
Figure 37. Other Organic Acids
Figure 38. World Nonnarcotic Analgesics Production Market Share by Type (2017-2028)
Figure 39. World Nonnarcotic Analgesics Production Value Market Share by Type (2017-2028)
Figure 40. World Nonnarcotic Analgesics Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Nonnarcotic Analgesics Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Nonnarcotic Analgesics Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Pharmacy
Figure 45. Specialist Clinic
Figure 46. Other
Figure 47. World Nonnarcotic Analgesics Production Market Share by Application (2017-2028)
Figure 48. World Nonnarcotic Analgesics Production Value Market Share by Application (2017-2028)
Figure 49. World Nonnarcotic Analgesics Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Nonnarcotic Analgesics in 2021
Figure 51. Manufacturing Process Analysis of Nonnarcotic Analgesics
Figure 52. Nonnarcotic Analgesics Industrial Chain
Figure 53. Distribution Channel Breakdown for Nonnarcotic Analgesics Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Nonnarcotic Analgesics Picture
Figure 2. World Nonnarcotic Analgesics Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Nonnarcotic Analgesics Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 5. World Nonnarcotic Analgesics Average Price (2017-2028) & (US$/Unit)
Figure 6. World Nonnarcotic Analgesics Production Value Market Share by Region (2017-2028)
Figure 7. World Nonnarcotic Analgesics Production Market Share by Region (2017-2028)
Figure 8. North America Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 9. Europe Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 10. China Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 11. Japan Nonnarcotic Analgesics Production (2017-2028) & (K Units)
Figure 12. Nonnarcotic Analgesics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nonnarcotic Analgesics Demand (2017-2028) & (K Units)
Figure 15. World Nonnarcotic Analgesics Consumption Market Share by Region (2017-2028)
Figure 16. United States Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 17. China Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 18. Europe Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 19. Japan Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 20. South Korea Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 22. India Nonnarcotic Analgesics Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Nonnarcotic Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nonnarcotic Analgesics Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nonnarcotic Analgesics Markets in 2021
Figure 26. United States VS China: Nonnarcotic Analgesics Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Nonnarcotic Analgesics Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Nonnarcotic Analgesics Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Nonnarcotic Analgesics in United States
Figure 30. Key Producers and Market Share of Nonnarcotic Analgesics in China
Figure 31. Key Producers and Market Share of Nonnarcotic Analgesics in Rest of World
Figure 32. World Nonnarcotic Analgesics Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Nonnarcotic Analgesics Production Value Market Share by Type in 2021
Figure 34. Salicylates
Figure 35. Anilines
Figure 36. Pyrazolones
Figure 37. Other Organic Acids
Figure 38. World Nonnarcotic Analgesics Production Market Share by Type (2017-2028)
Figure 39. World Nonnarcotic Analgesics Production Value Market Share by Type (2017-2028)
Figure 40. World Nonnarcotic Analgesics Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Nonnarcotic Analgesics Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Nonnarcotic Analgesics Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Pharmacy
Figure 45. Specialist Clinic
Figure 46. Other
Figure 47. World Nonnarcotic Analgesics Production Market Share by Application (2017-2028)
Figure 48. World Nonnarcotic Analgesics Production Value Market Share by Application (2017-2028)
Figure 49. World Nonnarcotic Analgesics Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Nonnarcotic Analgesics in 2021
Figure 51. Manufacturing Process Analysis of Nonnarcotic Analgesics
Figure 52. Nonnarcotic Analgesics Industrial Chain
Figure 53. Distribution Channel Breakdown for Nonnarcotic Analgesics Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
